0

Close
 
Upcoming Allied Market Research
2023
Vascular Closure Devices Market

Vascular Closure Devices Market: Global Opportunity Analysis and Industry Forecast 2023-2030 Market

LS : Medical Devices & Supplies
Report Code: A08371
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Vascular Closure Devices Market

Request Now !

Vascular closure device (VCD) are collagen pieces, sutures or metallic clip, which have been manufactured to supply immediate sealing of small penetrations in an artery after angiogram is performed. A blood vessel imaging is performed by the angiography of blood vessels, which are visible on pictures or X-ray images. This helps in the detection of abnormalities or disorders and finding out the cure for it. Access to arteries is generally performed via the femoral artery. Femoral arteries can run past all along the groins. These processes take place under the guidance of a specialist doctor after the artery is been penetrated and after a needle is passed through the skin. Once the angiographic procedure is complete, the plastic sheath helps to allow access to the femoral artery after the removal.

Vascular-Closure-Devices

COVID-19 scenario analysis:

  • To take care of the infected population, the demand for medical supplies is increasing. Respiratory support devices, such as atomizer, life-support machine, oxygen generator, and monitor, are among the majorly used medical devices in primary clinical treatment. 
  • Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in the number of COVID-19 cases worldwide, the need for medical supplies keeps on rising both from healthcare professionals and civil populations for precautionary measures. 
  • Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.
  • Attributed to such factors, COVID-19 is expected to have a significant impact on the gamma probe device market.

Top impacting factors: Market scenario analysis, trends, drivers and impact analysis

Rise in FDA approvals for VCD, increase in frequencies of cardiovascular diseases, rise in obesity levels, and rise in focus of manufacturers on large-bore vascular closure devices are the major factors propelling the growth of the vascular closure devices market. These vascular closure devices receive approvals from the FDA, government initiatives, and regulations. Betterment of patient treatment, demand for advanced treatment, rise in number of clinical trials & research activities, and advances in the manufacturers’ new products affect the growth of the vascular closure devices market. The efficiency rate of the devices is improving. Factors, such as improving frequencies of cardiovascular diseases and rise in obesity levels, also drive the growth of the vascular closure devices market.

On the other hand, malfunctioning of the devices, lack of quality products, and performance issues in the devices leading to product recalls & failures are the major challenges faced in the vascular closure devices market. Replacements in products and monetary losses after recalls to the manufacturers affect the growth of the market negatively.

New product launches to boost the market

On November 9th, 2015, Medtronic introduced the VenaSeal closure system in the U.S. This system got approval from the FDA under the Pre-market Approval (PMA) process.

Surge in usage in acute care facility applications

Acute care facilities, clinics, and hospitals are the major consumers of the vascular closure devices market. Amongst them, acute care facilities are the biggest end users in the market. There has also been rise in the case of cardiovascular diseases, which are needed for instant treatment and have made aware about VCDs in acute care treatment. Additionally, the utilization of technologies in imaging, such as echocardiography, in acute care for the CVD propels the market growth.

Key benefits of the report:

  • This study presents the analytical depiction of the vascular closure devices market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the vascular closure devices market share.
  • The current market is quantitatively analyzed to highlight the vascular closure devices market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the vascular closure devices market research report:

  • Which are the leading market players active in the vascular closure devices market?
  • What are the current trends that will influence the vascular closure devices market in the next few years?
  • What are the driving factors, restraints, and opportunities of the vascular closure devices market?
  • What are the projections for the future that would help in taking further strategic steps?

 Vascular Closure Devices Market: Global Opportunity Analysis and Industry Forecast 2020–2027 Report Highlights

Aspects Details
By Type
  • Passive Approximators
    • Collagen Plugs
    • Sealant- or Gel-based Devices
    • Compression-assist Devices
  • Active Approximators
    • Suture-based Devices
    • Clip-based Devices
    • External Hemostatic Devices
By Access
  • Femoral
  • Radial
By Procedure
  • Interventional Cardiology
  • Interventional Radiology/Vascular Surgery
By Region
  • North America  (US, Canada)
  • Europe  (Germany, UK, France, rest of Europe)
  • Asia-Pacific  (China, Japan, India, rest of Asia-Pacific)
  • Latin America  (Brazil, Mexico, rest of LATAM)
  • the Middle East 
  • Africa 
Key Market Players Abbott Vascular, W L. Gore & Associates, Merit Medical Systems, Inc., Cardival Medical, Inc., ST. JUDE MEDICAL, Cardinal Health, Biotronik GMBH & CO.KG, ESSENTIAL MEDICAL, Inc., Medtronic, Boston Scientific Corporation, C. R. Bard, Inc., TZ Medical, Inc., Scion BioMedical, COOK
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: VASCULAR CLOSURE DEVICES MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Passive Approximators

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Collagen Plugs

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Sealant- or Gel-based Devices

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Compression-assist Devices

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Active Approximators

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Suture-based Devices

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Clip-based Devices

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. External Hemostatic Devices

        • 4.3.4.1. Market Size and Forecast

  • CHAPTER 5: VASCULAR CLOSURE DEVICES MARKET, BY ACCESS

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Access

    • 5.2. Femoral

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Radial

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Procedure

    • 6.2. Interventional Cardiology

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Interventional Radiology/Vascular Surgery

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: VASCULAR CLOSURE DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Access

      • 7.2.4. Market Size and Forecast, By Procedure

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Vascular Closure Devices Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Access
        • 7.2.6.3. Market Size and Forecast, By Procedure

      • 7.2.7. Canada Vascular Closure Devices Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Access
        • 7.2.7.3. Market Size and Forecast, By Procedure

      • 7.2.8. Mexico Vascular Closure Devices Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Access
        • 7.2.8.3. Market Size and Forecast, By Procedure

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Access

      • 7.3.4. Market Size and Forecast, By Procedure

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Vascular Closure Devices Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Access
        • 7.3.6.3. Market Size and Forecast, By Procedure

      • 7.3.7. Germany Vascular Closure Devices Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Access
        • 7.3.7.3. Market Size and Forecast, By Procedure

      • 7.3.8. Italy Vascular Closure Devices Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Access
        • 7.3.8.3. Market Size and Forecast, By Procedure

      • 7.3.9. Spain Vascular Closure Devices Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Access
        • 7.3.9.3. Market Size and Forecast, By Procedure

      • 7.3.10. UK Vascular Closure Devices Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Access
        • 7.3.10.3. Market Size and Forecast, By Procedure

      • 7.3.11. Russia Vascular Closure Devices Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Access
        • 7.3.11.3. Market Size and Forecast, By Procedure

      • 7.3.12. Rest Of Europe Vascular Closure Devices Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Access
        • 7.3.12.3. Market Size and Forecast, By Procedure

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Access

      • 7.4.4. Market Size and Forecast, By Procedure

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Vascular Closure Devices Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Access
        • 7.4.6.3. Market Size and Forecast, By Procedure

      • 7.4.7. Japan Vascular Closure Devices Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Access
        • 7.4.7.3. Market Size and Forecast, By Procedure

      • 7.4.8. India Vascular Closure Devices Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Access
        • 7.4.8.3. Market Size and Forecast, By Procedure

      • 7.4.9. South Korea Vascular Closure Devices Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Access
        • 7.4.9.3. Market Size and Forecast, By Procedure

      • 7.4.10. Australia Vascular Closure Devices Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Access
        • 7.4.10.3. Market Size and Forecast, By Procedure

      • 7.4.11. Thailand Vascular Closure Devices Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Access
        • 7.4.11.3. Market Size and Forecast, By Procedure

      • 7.4.12. Malaysia Vascular Closure Devices Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Access
        • 7.4.12.3. Market Size and Forecast, By Procedure

      • 7.4.13. Indonesia Vascular Closure Devices Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Access
        • 7.4.13.3. Market Size and Forecast, By Procedure

      • 7.4.14. Rest of Asia Pacific Vascular Closure Devices Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Access
        • 7.4.14.3. Market Size and Forecast, By Procedure

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Access

      • 7.5.4. Market Size and Forecast, By Procedure

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Vascular Closure Devices Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Access
        • 7.5.6.3. Market Size and Forecast, By Procedure

      • 7.5.7. South Africa Vascular Closure Devices Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Access
        • 7.5.7.3. Market Size and Forecast, By Procedure

      • 7.5.8. Saudi Arabia Vascular Closure Devices Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Access
        • 7.5.8.3. Market Size and Forecast, By Procedure

      • 7.5.9. UAE Vascular Closure Devices Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Access
        • 7.5.9.3. Market Size and Forecast, By Procedure

      • 7.5.10. Argentina Vascular Closure Devices Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Access
        • 7.5.10.3. Market Size and Forecast, By Procedure

      • 7.5.11. Rest of LAMEA Vascular Closure Devices Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Access
        • 7.5.11.3. Market Size and Forecast, By Procedure

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Merit Medical Systems, Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Abbott Vascular

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Biotronik GMBH And CO.KG

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. COOK

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Medtronic

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Boston Scientific Corporation

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. C. R. Bard, Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. ESSENTIAL MEDICAL, Inc.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Cardinal Health

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. W L. Gore And Associates

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. ST. JUDE MEDICAL

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. TZ Medical, Inc.

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

    • 9.13. Cardival Medical, Inc.

      • 9.13.1. Company Overview

      • 9.13.2. Key Executives

      • 9.13.3. Company Snapshot

      • 9.13.4. Operating Business Segments

      • 9.13.5. Product Portfolio

      • 9.13.6. Business Performance

      • 9.13.7. Key Strategic Moves and Developments

    • 9.14. Scion BioMedical

      • 9.14.1. Company Overview

      • 9.14.2. Key Executives

      • 9.14.3. Company Snapshot

      • 9.14.4. Operating Business Segments

      • 9.14.5. Product Portfolio

      • 9.14.6. Business Performance

      • 9.14.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL VASCULAR CLOSURE DEVICES MARKET FOR PASSIVE APPROXIMATORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL VASCULAR CLOSURE DEVICES MARKET FOR ACTIVE APPROXIMATORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL VASCULAR CLOSURE DEVICES MARKET FOR FEMORAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL VASCULAR CLOSURE DEVICES MARKET FOR RADIAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA VASCULAR CLOSURE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 15. U.S. VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 16. U.S. VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 17. U.S. VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 18. CANADA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. CANADA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 20. CANADA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. MEXICO VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE VASCULAR CLOSURE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 25. EUROPE VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 28. FRANCE VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. FRANCE VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 30. FRANCE VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 34. ITALY VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. ITALY VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 36. ITALY VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 37. SPAIN VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. SPAIN VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 39. SPAIN VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 40. UK VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. UK VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 42. UK VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 43. RUSSIA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. RUSSIA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 45. RUSSIA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC VASCULAR CLOSURE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 53. CHINA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. CHINA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 55. CHINA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 59. INDIA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. INDIA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 61. INDIA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH KOREA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH KOREA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 68. THAILAND VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 69. THAILAND VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 70. THAILAND VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 71. MALAYSIA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. MALAYSIA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 73. MALAYSIA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 74. INDONESIA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. INDONESIA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 76. INDONESIA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 77. REST OF ASIA PACIFIC VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 78. REST OF ASIA PACIFIC VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 80. LAMEA VASCULAR CLOSURE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 81. LAMEA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 82. LAMEA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 83. LAMEA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 84. BRAZIL VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 85. BRAZIL VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 86. BRAZIL VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH AFRICA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH AFRICA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH AFRICA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 90. SAUDI ARABIA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 91. SAUDI ARABIA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 92. SAUDI ARABIA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 93. UAE VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 94. UAE VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 95. UAE VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 96. ARGENTINA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 97. ARGENTINA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 98. ARGENTINA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 99. REST OF LAMEA VASCULAR CLOSURE DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 100. REST OF LAMEA VASCULAR CLOSURE DEVICES, BY ACCESS, 2022-2032 ($MILLION)
  • TABLE 101. REST OF LAMEA VASCULAR CLOSURE DEVICES, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 102. MERIT MEDICAL SYSTEMS, INC.: KEY EXECUTIVES
  • TABLE 103. MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
  • TABLE 104. MERIT MEDICAL SYSTEMS, INC.: OPERATING SEGMENTS
  • TABLE 105. MERIT MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
  • TABLE 106. MERIT MEDICAL SYSTEMS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. ABBOTT VASCULAR: KEY EXECUTIVES
  • TABLE 108. ABBOTT VASCULAR: COMPANY SNAPSHOT
  • TABLE 109. ABBOTT VASCULAR: OPERATING SEGMENTS
  • TABLE 110. ABBOTT VASCULAR: PRODUCT PORTFOLIO
  • TABLE 111. ABBOTT VASCULAR: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. BIOTRONIK GMBH AND CO.KG: KEY EXECUTIVES
  • TABLE 113. BIOTRONIK GMBH AND CO.KG: COMPANY SNAPSHOT
  • TABLE 114. BIOTRONIK GMBH AND CO.KG: OPERATING SEGMENTS
  • TABLE 115. BIOTRONIK GMBH AND CO.KG: PRODUCT PORTFOLIO
  • TABLE 116. BIOTRONIK GMBH AND CO.KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. COOK: KEY EXECUTIVES
  • TABLE 118. COOK: COMPANY SNAPSHOT
  • TABLE 119. COOK: OPERATING SEGMENTS
  • TABLE 120. COOK: PRODUCT PORTFOLIO
  • TABLE 121. COOK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. MEDTRONIC: KEY EXECUTIVES
  • TABLE 123. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 124. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 125. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 126. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 128. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 129. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 130. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 131. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. C. R. BARD, INC.: KEY EXECUTIVES
  • TABLE 133. C. R. BARD, INC.: COMPANY SNAPSHOT
  • TABLE 134. C. R. BARD, INC.: OPERATING SEGMENTS
  • TABLE 135. C. R. BARD, INC.: PRODUCT PORTFOLIO
  • TABLE 136. C. R. BARD, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. ESSENTIAL MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 138. ESSENTIAL MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 139. ESSENTIAL MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 140. ESSENTIAL MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 141. ESSENTIAL MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. CARDINAL HEALTH: KEY EXECUTIVES
  • TABLE 143. CARDINAL HEALTH: COMPANY SNAPSHOT
  • TABLE 144. CARDINAL HEALTH: OPERATING SEGMENTS
  • TABLE 145. CARDINAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 146. CARDINAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. W L. GORE AND ASSOCIATES: KEY EXECUTIVES
  • TABLE 148. W L. GORE AND ASSOCIATES: COMPANY SNAPSHOT
  • TABLE 149. W L. GORE AND ASSOCIATES: OPERATING SEGMENTS
  • TABLE 150. W L. GORE AND ASSOCIATES: PRODUCT PORTFOLIO
  • TABLE 151. W L. GORE AND ASSOCIATES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. ST. JUDE MEDICAL: KEY EXECUTIVES
  • TABLE 153. ST. JUDE MEDICAL: COMPANY SNAPSHOT
  • TABLE 154. ST. JUDE MEDICAL: OPERATING SEGMENTS
  • TABLE 155. ST. JUDE MEDICAL: PRODUCT PORTFOLIO
  • TABLE 156. ST. JUDE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. TZ MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 158. TZ MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 159. TZ MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 160. TZ MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 161. TZ MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. CARDIVAL MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 163. CARDIVAL MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 164. CARDIVAL MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 165. CARDIVAL MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 166. CARDIVAL MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. SCION BIOMEDICAL: KEY EXECUTIVES
  • TABLE 168. SCION BIOMEDICAL: COMPANY SNAPSHOT
  • TABLE 169. SCION BIOMEDICAL: OPERATING SEGMENTS
  • TABLE 170. SCION BIOMEDICAL: PRODUCT PORTFOLIO
  • TABLE 171. SCION BIOMEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR CLOSURE DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL VASCULAR CLOSURE DEVICES MARKET
  • FIGURE 3. SEGMENTATION VASCULAR CLOSURE DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN VASCULAR CLOSURE DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALVASCULAR CLOSURE DEVICES MARKET
  • FIGURE 11. VASCULAR CLOSURE DEVICES MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. VASCULAR CLOSURE DEVICES MARKET FOR PASSIVE APPROXIMATORS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. VASCULAR CLOSURE DEVICES MARKET FOR ACTIVE APPROXIMATORS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. VASCULAR CLOSURE DEVICES MARKET SEGMENTATION, BY BY ACCESS
  • FIGURE 15. VASCULAR CLOSURE DEVICES MARKET FOR FEMORAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. VASCULAR CLOSURE DEVICES MARKET FOR RADIAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. VASCULAR CLOSURE DEVICES MARKET SEGMENTATION, BY BY PROCEDURE
  • FIGURE 18. VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. VASCULAR CLOSURE DEVICES MARKET FOR INTERVENTIONAL RADIOLOGY/VASCULAR SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: VASCULAR CLOSURE DEVICES MARKET
  • FIGURE 26. Top player positioning, 2022
  • FIGURE 27. MERIT MEDICAL SYSTEMS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. MERIT MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. MERIT MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. ABBOTT VASCULAR: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. ABBOTT VASCULAR: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. ABBOTT VASCULAR: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. BIOTRONIK GMBH AND CO.KG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. BIOTRONIK GMBH AND CO.KG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. BIOTRONIK GMBH AND CO.KG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. COOK: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. COOK: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. COOK: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. C. R. BARD, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. C. R. BARD, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. C. R. BARD, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. ESSENTIAL MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. ESSENTIAL MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. ESSENTIAL MEDICAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. CARDINAL HEALTH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. W L. GORE AND ASSOCIATES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. W L. GORE AND ASSOCIATES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. W L. GORE AND ASSOCIATES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. ST. JUDE MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. ST. JUDE MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. ST. JUDE MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. TZ MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. TZ MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. TZ MEDICAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. CARDIVAL MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. CARDIVAL MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. CARDIVAL MEDICAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. SCION BIOMEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. SCION BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. SCION BIOMEDICAL: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Vascular Closure Devices Market

Start reading.
This Report and over 68,113+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers